Anemia due to chronic kidney disease
Anemia is a common blood disorder characterized by a lower-than-normal number of red blood cells or a reduced ability of the red blood cells to carry oxygen throughout the body. In the context of chronic kidney disease (CKD), anemia can develop as a result of the kidneys’ reduced ability to produce a hormone called erythropoietin, which stimulates the production of red blood cells in the bone marrow. Additionally, an accumulation of waste products in the blood, such as uremia, can lead to the destruction of red blood cells.
Typical Medications:
Erythropoiesis-stimulating agents (ESAs): These medications, such as epoetin alfa and darbepoetin alfa, mimic the function of erythropoietin and stimulate the production of red blood cells in the bone marrow.
Iron supplements: Iron is an essential component of hemoglobin, the protein in red blood cells that binds to oxygen. In patients with CKD-related anemia, iron supplements may be necessary to support the production of new red blood cells.
Vitamin B12 and folic acid: These vitamins play a crucial role in the synthesis of red blood cells. In patients with CKD-related anemia, supplementation with vitamin B12 and folic acid may be necessary to optimize red blood cell production.
Note: Always consult with a healthcare professional before starting any new medication or making changes to your current treatment plan.

Showing 1–12 of 70 results
-
Darbepoetin alfa (57)
-
Desidustat (5)
-
Methoxy polyethylene glycol-epoetin beta (6)
-
Recombinant Human Erythropoietin Beta (2)
Showing 1–12 of 70 results